B. Peshkin

发表

Author Correction: Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis

C. Isaacs, V. Jin, Xiaowen Zhang, 2018, Nature communications.

Multigene Cancer Panels: Implications for Pre- and Post-test Genetic Counseling

B. Peshkin, Margo C. Grady, Kavitha A. Kolla, 2019, Current Genetic Medicine Reports.

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Giovanni Parmigiani, Susan G Hilsenbeck, Judy E Garber, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants

B. Peshkin, K. Tercyak, C. Lerman, 2001, Psycho-oncology.

All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.

C. Isaacs, B. Peshkin, M. Schwartz, 2002, American journal of medical genetics.

Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.

W. Lawrence, C. Isaacs, B. Peshkin, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jaana M. Hartikainen, W. Chung, 2019, Nature Genetics.

Interest in genetic counseling and testing for adolescent nicotine addiction susceptibility among a sample of adolescent medicine providers attending a scientific conference on adolescent health.

B. Peshkin, K. Tercyak, A. Abraham, 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Talking to Children About Maternal BRCA1/2 Genetic Test Results: A Qualitative Study of Parental Perceptions and Advice

A. Patenaude, J. Garber, H. Valdimarsdottir, 2013, Journal of Genetic Counseling.

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.

C. Magnant, C. Isaacs, B. Peshkin, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development of an Interactive Decision Aid for Female BRCA1/BRCA2 Carriers

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2003, Journal of Genetic Counseling.

Billing and Record-Keeping for Familial Cancer Risk Counseling: A National Survey

B. Bernhardt, B. Peshkin, Y. Kemel, 1998, Journal of Genetic Counseling.

Women’s concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children

A. Patenaude, J. Garber, B. Peshkin, 2014, Journal of Community Genetics.

Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.

C. Isaacs, B. Peshkin, M. Schwartz, 2003, Journal of Clinical Oncology.

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

Jack A. Taylor, W. Chung, S. Cross, 2019, bioRxiv.

Adolescent medical providers' willingness to recommend genetic susceptibility testing for nicotine addiction and lung cancer risk to adolescents.

B. Peshkin, K. Tercyak, G. Luta, 2009, Journal of pediatric psychology.

What W ould Y ou D o? Specialists' P erspectives o n C ancer G enetic T esting, Prophylactic S urgery, a nd I nsurance D iscrimination

B. Bernhardt, B. Peshkin, H. Shappell, 2000 .

Hereditary Breast Cancer: an Overview

C. Isaacs, B. Peshkin, 1999 .

Primary care providers’ willingness to recommend BRCA1/2 testing to adolescents

B. Peshkin, K. Tercyak, G. Luta, 2010, Familial Cancer.

Oncofertility in adolescent and young adult hereditary cancer: Considerations for genetics professionals

B. Peshkin, S. Vadaparampil, G. Quinn, 2015 .

Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk

A. Whittemore, W. Chung, L. Kiemeney, 2020, medRxiv.

Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors

B. Peshkin, K. Graves, Neha Rajpal, 2017, Journal of Genetic Counseling.

Conveying genomic recurrence risk estimates to patients with early‐stage breast cancer: oncologist perspectives

C. Isaacs, B. Peshkin, M. Schwartz, 2013, Psycho-oncology.

Deleterious BRCA1/2 mutations in an urban population of Black women

C. Isaacs, B. Peshkin, Hongkun Wang, 2015, Breast Cancer Research and Treatment.

Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women

C. McBride, B. Peshkin, M. Schwartz, 2022, Journal of Community Genetics.

Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: a qualitative investigation of impact on children's genetic health literacy and psychosocial adjustment.

Hillary A. Robertson, B. Peshkin, Hillary A Robertson, 2019, Translational behavioral medicine.

Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.

C. Magnant, C. Isaacs, B. Peshkin, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients

H. Valdimarsdottir, C. Isaacs, Elizabeth Poggi, 2020, Breast Cancer Research and Treatment.

Psychosocial Issues in BRCA1/2 Testing

B. Peshkin, C. Lerman, 1999 .

Long-Term Psychosocial Outcomes of BRCA1/BRCA2 Testing: Differences across Affected Status and Risk-Reducing Surgery Choice

C. Isaacs, Elizabeth Poggi, B. Peshkin, 2012, Cancer Epidemiology, Biomarkers and Prevention.

BRCA1/2 genetic testing uptake and psychosocial outcomes in men

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2011, Familial Cancer.

Hereditary Cancer Risk

B. Peshkin, J. Axilbund, 2010 .

Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2018, Breast Cancer Research and Treatment.

Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.

A. Patenaude, J. Garber, H. Valdimarsdottir, 2007, Genetic testing.

Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives

A. Patenaude, B. Peshkin, J. Hamilton, 2018, Psycho-oncology.

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors

C. Isaacs, B. Peshkin, M. Schwartz, 2006, Breast Cancer Research and Treatment.

Breast and Ovarian Cancer Screening Practices in Healthy Women with a Strong Family History of Breast or Ovarian Cancer

C. Isaacs, B. Peshkin, M. Schwartz, 2004, Breast Cancer Research and Treatment.

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.

D. Cella, A. Peterman, B. Peshkin, 2002, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Intentions for bilateral mastectomy among newly diagnosed breast cancer patients

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2013, Journal of surgical oncology.

Familial Breast Cancer: Genetic Testing

B. Peshkin, C. Lerman, 2006 .

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.

C. Isaacs, B. Peshkin, M. Schwartz, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.

C. Isaacs, B. Peshkin, M. Schwartz, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Genetic counselling for hereditary breast cancer

B. Peshkin, C. Lerman, 1999, The Lancet.

BRCA1/2 testing in patients with newly diagnosed breast cancer

B. Peshkin, McKinsey L Goodenberger, T. Demarco, 2009 .

Predictors of Enrollment into a Familial Cancer Registry by Individuals at High Risk for BRCA1/2

C. Isaacs, B. Peshkin, M. Schwartz, 2006, Cancer Epidemiology Biomarkers & Prevention.

Interest of adolescents in genetic testing for nicotine addiction susceptibility.

B. Peshkin, K. Tercyak, L. Wine, 2006, Preventive medicine.

Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.

A. Patenaude, J. Garber, B. Peshkin, 2014, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Multidisciplinary genetic assessment has similar psychological impact to usual care for women at high risk of familial breast cancer

B. Peshkin, M. Schwartz, 2002 .

Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers

R. Nussbaum, F. Couch, J. Benítez, 2017, European Journal of Human Genetics.

Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.

A. Patenaude, J. Garber, H. Valdimarsdottir, 2012, Genetic testing and molecular biomarkers.

Family Disclosure in Genetic Testing for Cancer Susceptibility: Determinants and Consequences

C. Isaacs, B. Peshkin, C. Lerman, 1998 .

Randomized Controlled Trial of a Psychosocial Telephone Counseling Intervention in BRCA 1 and BRCA 2 Mutation Carriers

D. Cella, B. Peshkin, M. Schwartz, 2010 .

RE: Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.

C. Isaacs, B. Peshkin, M. Schwartz, 2019, Journal of the National Cancer Institute.

Uptake of BRCA1/2 Genetic Testing in a Randomized Trial of Telephone Counseling

J. Garber, H. Valdimarsdottir, C. Isaacs, 2014, Genetics in Medicine.

Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk.

C. Isaacs, J. Garber, B. Peshkin, 2022, Pediatrics.

Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.

A. Patenaude, J. Garber, H. Valdimarsdottir, 2010, Patient education and counseling.

Women's satisfaction with genetic counseling for hereditary breast‐ovarian cancer: Psychological aspects

B. Peshkin, K. Tercyak, T. Demarco, 2004, American journal of medical genetics. Part A.

Patient Satisfaction with Cancer Genetic Counseling: A Psychometric Analysis of the Genetic Counseling Satisfaction Scale

B. Peshkin, K. Tercyak, T. Demarco, 2004, Journal of Genetic Counseling.

Psychosocial impact of proactive rapid genetic counseling following breast cancer diagnosis

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2021, Psycho-oncology.

Decisional Outcomes of Maternal Disclosure of BRCA1/2 Genetic Test Results to Children

A. Patenaude, J. Garber, H. Valdimarsdottir, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Validity of Models for Predicting BRCA1 and BRCA2 Mutations

Leif E. Peterson, Giovanni Parmigiani, Li Hsu, 2007, Annals of Internal Medicine.

Breast cancer risk assessment and genetic testing: complexities, conundrums, and community.

B. Peshkin, 2006, Breast disease.

Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.

B. Peshkin, S. Swain, N. Brandt, 2020, Pharmacogenomics.

Genetic counseling and testing for hereditary cancer risk in young adult women: Facilitating autonomy and informed decision making is key

B. Peshkin, S. Vadaparampil, Suzanne M. O’Neill, 2015, Gynecologic oncology reports.

Impact of genetic information and genetic counseling on public health

B. Peshkin, J. Benkendorf, C. Lerman, 2000 .

Oophorectomy in carriers of BRCA mutations [3]

T. Rebbeck, B. Weber, K. Offit, 2002 .

Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: The contributions of personality and appraisal

B. Peshkin, M. Schwartz, B. Biesecker, 1997, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

BRCA1/2 mutations and risk‐reducing bilateral salpingo‐oophorectomy among Latinas: The UPTAKE study

C. Isaacs, B. Peshkin, S. Friedman, 2020, Journal of genetic counseling.

Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population

C. Isaacs, B. Peshkin, S. Friedman, 2017, Familial Cancer.

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Päivi Heikkilä, Mads Thomassen, Stephen Fox, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Jack A. Taylor, W. Chung, S. Cross, 2019, bioRxiv.

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

D. B. Berman, F. Couch, T. Rebbeck, 1996, Nature Medicine.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

S. Cummings, S. Loader, P. Rowley, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

Leif E. Peterson, Giovanni Parmigiani, Christopher I Amos, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bioethics of Genetic Testing for Hereditary Breast Cancer

B. Peshkin, W. Burke, 2007 .

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.

J. Garber, H. Valdimarsdottir, C. Isaacs, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Utilization of BRCA 1 / BRCA 2 Mutation Testing in Newly Diagnosed Breast Cancer Patients

C. Isaacs, B. Peshkin, M. Schwartz, 2005 .

BRCA1/2 testing: complex themes in result interpretation.

C. Isaacs, B. Peshkin, C. Lerman, 2001, Journal of Clinical Oncology.

What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination.

B. Bernhardt, B. Peshkin, H. Shappell, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis

M. Pujana, C. Isaacs, V. Jin, 2017, Nature Communications.

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

A. Whittemore, W. Chung, L. Kiemeney, 2022, European Journal of Human Genetics.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women

B. Peshkin, V. Sheppard, D. Mays, 2012, Familial Cancer.

The Essentials of Multiomics

C. Haudenschild, D. Kerr, G. Melino, 2022, The oncologist.

Pathology of Breast andOvarian Cancers among BRCA 1 and BRCA 2 Mutation Carriers : Results from the Consortium of Investigators of Modi fi ers of BRCA 1 / 2 ( CIMBA )

R. Nussbaum, V. Pankratz, F. Couch, 2011 .

Intentions for risk‐reducing surgery among high‐risk women referred for BRCA1/BRCA2 genetic counseling

J. Garber, H. Valdimarsdottir, B. Peshkin, 2015, Psycho-oncology.

BRCA1/2 test results impact risk management attitudes, intentions, and uptake

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2010, Breast Cancer Research and Treatment.

BRCA1/2 mutations and triple negative breast cancers.

C. Isaacs, B. Peshkin, Claudine Isaacs, 2010, Breast disease.

Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.

Suzanne O'Neill, Suzanne Leaman, H. Valdimarsdottir, 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Genetic Discrimination in Health Insurance: Current Legal Protections and Industry Practices

B. Peshkin, K. Pollitz, Eliza Bangit, 2007, Inquiry : a journal of medical care organization, provision and financing.

Utilization of BRCA1/BRCA2 Mutation Testing in Newly Diagnosed Breast Cancer Patients

C. Isaacs, B. Peshkin, M. Schwartz, 2005, Cancer Epidemiology Biomarkers & Prevention.

Results of a randomized controlled trial of a decision support intervention for disclosing maternal BRCA genetic test results to children and adolescents

J. Garber, C. Isaacs, B. Peshkin, 2023, PEC innovation.

Improving our model of cascade testing for hereditary cancer risk by leveraging patient peer support: a concept report

C. Isaacs, M. Robson, B. Peshkin, 2021, Hereditary cancer in clinical practice.

Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population

C. Isaacs, B. Peshkin, S. Friedman, 2018, Familial Cancer.

Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support

C. Isaacs, B. Peshkin, C. Evans, 2016, Healthcare.

Parent-child factors and their effect on communicating BRCA1/2 test results to children.

B. Peshkin, K. Tercyak, C. Lerman, 2002, Patient education and counseling.

Providers’ Perceptions and Practices Regarding BRCA1/2 Genetic Counseling and Testing in African American Women

C. Isaacs, B. Peshkin, V. Sheppard, 2011, Journal of Genetic Counseling.

Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?

B. Rimer, D. Cella, J. Garber, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Women’s concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children

A. Patenaude, J. Garber, B. Peshkin, 2014, Journal of Community Genetics.

Psychosocial Impact of Predictive Testing for Illness on Children and Families: Challenges for a New Millennium

B. Peshkin, K. Tercyak, C. Lerman, 2000, Journal of Clinical Psychology in Medical Settings.

Interest in Genetic Testing for Modest Changes in Breast Cancer Risk: Implications for SNP Testing

B. Peshkin, M. Schwartz, G. Luta, 2011, Public Health Genomics.

Long‐term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance

C. Isaacs, Elizabeth Poggi, B. Peshkin, 2012, Cancer.

Parental decisions and outcomes regarding disclosing maternal BRCA1 and 2 test results to children.

A. Patenaude, J. Garber, H. Valdimarsdottir, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Uptake of BRCA1/2 Genetic Testing in a Randomized Trial of Telephone Counseling

J. Garber, H. Valdimarsdottir, C. Isaacs, 2014, Genetics in Medicine.

Culturally Targeted Video Improves Psychosocial Outcomes in Latina Women at Risk of Hereditary Breast and Ovarian Cancer

B. Peshkin, V. Sheppard, M. Schwartz, 2019, International journal of environmental research and public health.

The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families

C. Isaacs, B. Peshkin, M. Schwartz, 2019, Journal of Cancer Education.

Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up

J. Garber, H. Valdimarsdottir, C. Isaacs, 2017, JNCI cancer spectrum.

Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas.

S. Buys, B. Peshkin, J. Mandelblatt, 2016, Journal of oncology practice.

The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families

C. Isaacs, B. Peshkin, M. Schwartz, 2019, Journal of Cancer Education.

Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).

A. Patenaude, J. Garber, H. Valdimarsdottir, 2009, Journal of pediatric psychology.

Longitudinal Changes in Patient Distress following Interactive Decision Aid Use among BRCA1/2 Carriers

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

Decision making and decision support for hereditary breast-ovarian cancer susceptibility.

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2005, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.

C. Isaacs, B. Peshkin, M. Schwartz, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictors of genetic testing uptake in newly diagnosed breast cancer patients

H. Valdimarsdottir, C. Isaacs, B. Peshkin, 2020, Journal of surgical oncology.

Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer.

B. Peshkin, V. Sheppard, M. Schwartz, 2023, Translational behavioral medicine.

Telephone versus in-person genetic counseling for hereditary cancer risk: Patient predictors of differential outcomes

J. Garber, H. Valdimarsdottir, C. Isaacs, 2021, Journal of telemedicine and telecare.

Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2016, Familial Cancer.

Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2008, Genetic testing.

Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS

C. Isaacs, B. Peshkin, M. Schwartz, 2012, Journal of Cancer Epidemiology.

Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings

B. Peshkin, S. Swain, D. M. Smith, 2020, Clinical and translational science.

Behavioral and psychosocial responses to genomic testing for colorectal cancer risk.

B. Peshkin, P. Shields, M. Schwartz, 2013, Genomics.

Cigarette Smoking Among Youth with Attention-Deficit/Hyperactivity Disorder: Clinical Phenomenology, Comorbidity, and Genetics

B. Peshkin, K. Tercyak, M. Stein, 2002, Journal of Clinical Psychology in Medical Settings.

Process evaluation of a culturally targeted video for Latinas at risk of hereditary breast and ovarian cancer

B. Peshkin, V. Sheppard, M. Schwartz, 2020, Journal of genetic counseling.

Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women

B. Peshkin, V. Sheppard, D. Mays, 2012, Familial Cancer.

Changes in Diet and Physical Activity Following BRCA1/2 Testing

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2008, Journal of psychosocial oncology.

Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results.

Rachel E. Goldsmith, H. Valdimarsdottir, B. Peshkin, 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2006, American journal of medical genetics. Part C, Seminars in medical genetics.

Correlates of Adherence to a Telephone-Based Multiple Health Behavior Change Cancer Preventive Intervention for Teens

B. Peshkin, D. Mays, K. Tercyak, 2012, Health education & behavior : the official publication of the Society for Public Health Education.

Patterns and correlates of multiple risk factors for adult-onset cancer among adolescents1

B. Peshkin, D. Mays, K. Tercyak, 2012, Journal of child health care : for professionals working with children in the hospital and community.

Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations.

B. Peshkin, S. Narod, A. Marcus, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.

C. Isaacs, B. Peshkin, M. Schwartz, 2018, Translational behavioral medicine.

Spiritual faith and genetic testing decisions among high-risk breast cancer probands.

C. Isaacs, B. Peshkin, M. Schwartz, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

“Is it Really Worth it to Get Tested?”: Primary Care Patients’ Impressions of Predictive SNP Testing for Colon Cancer

B. Peshkin, M. Schwartz, K. Graves, 2013, Journal of Genetic Counseling.

Developing a culturally targeted video to enhance the use of genetic counseling in Latina women at increased risk for hereditary breast and ovarian cancer

B. Peshkin, V. Sheppard, M. Schwartz, 2019, Journal of Community Genetics.

Predictors of Cognitive Appraisals Following Genetic Testing for BRCA1 and BRCA2 Mutations

D. Cella, B. Peshkin, M. Schwartz, 2004, Journal of Behavioral Medicine.

Across the Spectrum: Case Studies in Genetic Counseling for Breast and Ovarian Cancer

B. Peshkin, T. Demarco, B. Brogan, 2001, Journal of Genetic Counseling.

Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community‐based organizations

B. Peshkin, V. Sheppard, M. Schwartz, 2023, Journal of genetic counseling.

Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers

C. Isaacs, Elizabeth Poggi, B. Peshkin, 2014, Hereditary cancer in clinical practice.

Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers

C. Isaacs, Elizabeth Poggi, B. Peshkin, 2014, Hereditary Cancer in Clinical Practice.

Randomized Controlled Trial of a Psychosocial Telephone Counseling Intervention in BRCA1 and BRCA2 Mutation Carriers

D. Cella, B. Peshkin, M. Schwartz, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines

C. Isaacs, B. Peshkin, S. Swain, 2016, Breast Cancer Research and Treatment.

Translational genomic research: protocol development and initial outcomes following SNP testing for colon cancer risk

B. Peshkin, P. Shields, M. Schwartz, 2013, Translational behavioral medicine.

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling

J. Garber, H. Valdimarsdottir, C. Isaacs, 2016, Journal of Genetic Counseling.

Development and pilot testing of a training for bilingual community education professionals about hereditary breast and ovarian cancer among Latinas: ÁRBOLES Familiares.

B. Peshkin, M. Schwartz, S. Vadaparampil, 2021, Translational behavioral medicine.

Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk.

C. Isaacs, B. Peshkin, M. Schwartz, 2001, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children

B. Peshkin, K. Tercyak, T. Demarco, 2010, Familial Cancer.

Discussing race-related limitations of genomic testing for colon cancer risk: implications for education and counseling.

B. Peshkin, M. Schwartz, G. Hooker, 2014, Social science & medicine.

Genetic testing: the bigger picture.

B. Peshkin, T. Demarco, 2012, Oncology.

Measuring high‐risk parents' opinions about direct‐to‐consumer genetic testing for adult‐onset inherited cancer syndromes in their adolescent and young adult children

B. Wilfond, C. Isaacs, B. Peshkin, 2023, Journal of genetic counseling.

Practical aspects of delivering hereditary cancer risk counseling.

C. Isaacs, B. Peshkin, M. Schwartz, 2007, Seminars in oncology.

Genetic counseling about reproductive options for hereditary cancer: what is the standard of care?

B. Peshkin, T. Demarco, Rachel Nusbaum, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

K Offit, A Oliphant, S. Loader, 1997, JAMA.

Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants

B. Peshkin, K. Tercyak, C. Lerman, 2001, Psycho-oncology.

Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility?

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2005, Nature Clinical Practice Oncology.

Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).

A. Patenaude, J. Garber, H. Valdimarsdottir, 2009, Journal of pediatric psychology.

Decisional Outcomes of Maternal Disclosure of BRCA1/2 Genetic Test Results to Children

A. Patenaude, J. Garber, H. Valdimarsdottir, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Long-Term Psychosocial Outcomes of BRCA1/BRCA2 Testing: Differences across Affected Status and Risk-Reducing Surgery Choice

C. Isaacs, Elizabeth Poggi, B. Peshkin, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2008, Genetic testing.

Evaluation of a longitudinal pharmacogenomics education on pharmacist knowledge in a multicampus healthcare system.

B. Peshkin, S. M. Swain, D. M. Smith, 2022, Pharmacogenomics.

Intentions for bilateral mastectomy among newly diagnosed breast cancer patients

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2013, Journal of surgical oncology.

Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer

H. Valdimarsdottir, B. Peshkin, M. Schwartz, 2016, Familial Cancer.

Evaluation and management of women with BRCA1/2 mutations.

C. Isaacs, B. Peshkin, 2005, Oncology.